See the Glossary for more terms.
Several investigators have graciously agreed to let us post their exceptional applications online.
We are truly indebted to the investigators listed below, who have enabled us to deliver this widely anticipated resource to the research community.
We selected these applications as sound examples of good grantsmanship, which we highlighted with annotations.
NB. The text of these applications is copyrighted. You may use it only for nonprofit educational purposes provided the document remains unchanged and the PI, the grantee organization, and NIAID are credited.
Depending on your local printer settings, you may need to adjust margins or page layout to print the full page.
Please note that the R21 funds novel scientific ideas, model systems, tools, agents, targets, and technologies that have the potential to substantially advance biomedical research. R21s are not intended for new investigators, and there is no evidence that they provide a path to an independent research career.
The R21/R33 supports a two-phased award without a break in funding. It begins with the R21 phase for milestone-driven exploratory or feasibility studies with a possible transition to the R33 phase for expanded development. Transition to the second phase depends on several factors, including the achievement of negotiated milestones.
For information about preparing the forms and page limits:
If you have knowledge to share or want more information on this topic, email firstname.lastname@example.org with this link and your message. Thanks for helping us clarify and expand our knowledge base.
Last Updated July 08, 2013
Last Reviewed June 06, 2012